title: Decreased cysteine and proline synthesis in parenterally fed, premature infants.
abstract: Little is known about the amino acid (AA) biosynthetic capacity and requirements of premature infants. This study assessed the synthesis of seven biochemically nonessential AA from a universal precursor, glucose, in stable, parenterally fed, premature neonates. Seven infants (six boys, one girl) were studied at a mean age of 6.3 +/- 0.6 (SEM) days; mean gestational age was 29.7 +/- 1.3 (SEM) weeks, and mean birth weight was 1,222.8 +/- 176.5 (SEM) grams. All infants were parenterally fed a mixture of 7.5% to 12.5% dextrose and 2.2% Trophamine, with or without lipid. Mean caloric intake was 93 +/- 8.4 (SEM) kcal/kg/d, and total AA intake was standardized at 2.86 g/kg/d AA, plus supplemental cysteine (30 mg/g AA/d). Each infant received a 4-hour continuous, unprimed intravenous infusion of a stable isotope tracer of D(-)[U13C] glucose (200 mg/kg). Blood samples were obtained before and at the end of the infusion. Conversion of the glucose tracer into seven biochemically nonessential AA (cysteine [Cys], proline [Pro], aspartate [Asp], serine [Ser], glutamate [Glu], alanine [Ala], and glycine [Gly]) was assessed by measuring their isotopic enrichment in plasma, using gas chromatography/mass spectrometry (GC/MS), and expressed as mole percent excess (MPE) (mean +/- SEM). The isotopic enrichment of plasma glucose was also measured using GC/MS. Free plasma AA concentrations (mean +/- SD) were measured using an automated amino acid analyzer. Mean MPE for M + 1, M + 2 and M + 3 Cys, and for M + 1 and M + 3 Pro were not significantly different from 0; M + 2 Pro barely achieved statistical significance (P = .048).(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000409:Alanine / Q000096:biosynthesis / Q000097:blood; D000596:Amino Acids / Q000008:administration & dosage; D001224:Aspartic Acid / Q000096:biosynthesis / Q000097:blood; D001724:Birth Weight; D001786:Blood Glucose / Q000032:analysis; D002247:Carbon Isotopes; D003545:Cysteine / Q000096:biosynthesis* / Q000097:blood; D004573:Electrolytes; D002149:Energy Intake; D005260:Female; D005526:Food, Formulated; D008401:Gas Chromatography-Mass Spectrometry; D005865:Gestational Age; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D018698:Glutamic Acid / Q000096:biosynthesis / Q000097:blood; D005998:Glycine / Q000096:biosynthesis / Q000097:blood; D006801:Humans; D007225:Infant Food; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood / Q000378:metabolism*; D008055:Lipids / Q000008:administration & dosage; D008297:Male; D010288:Parenteral Nutrition; D057947:Parenteral Nutrition Solutions; D011392:Proline / Q000096:biosynthesis* / Q000097:blood; D012694:Serine / Q000096:biosynthesis / Q000097:blood; D012996:Solutions
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D002247:Carbon Isotopes; D004573:Electrolytes; D008055:Lipids; D057947:Parenteral Nutrition Solutions; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D001224:Aspartic Acid; D018698:Glutamic Acid; D012694:Serine; D011392:Proline; D005947:Glucose; D003545:Cysteine; D000409:Alanine; D005998:Glycine